Epitopes, T-Lymphocyte

"Epitopes, T-Lymphocyte" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antigenic determinants recognized and bound by the T-cell receptor. Epitopes recognized by the T-cell receptor are often located in the inner, unexposed side of the antigen, and become accessible to the T-cell receptors after proteolytic processing of the antigen.

Descriptor ID	D018984
MeSH Number(s)	D23.050.550.402
Concept/Terms	Epitopes, T-Lymphocyte Epitopes, T-Lymphocyte Epitopes, T Lymphocyte T-Cell Epitopes Epitopes, T-Cell T Cell Epitopes T-Lymphocyte Epitopes T Lymphocyte Epitopes T-Cell Epitope Epitope, T-Cell T Cell Epitope T-Lymphocyte Epitope Epitope, T-Lymphocyte T Lymphocyte Epitope

Below are MeSH descriptors whose meaning is more general than "Epitopes, T-Lymphocyte".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Epitopes [D23.050.550]
Epitopes, T-Lymphocyte [D23.050.550.402]

Below are MeSH descriptors whose meaning is related to "Epitopes, T-Lymphocyte".

Below are MeSH descriptors whose meaning is more specific than "Epitopes, T-Lymphocyte".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Epitopes, T-Lymphocyte" by people in this website by year, and whether "Epitopes, T-Lymphocyte" was a major or minor topic of these publications.

Bar chart showing 36 publications over 17 distinct years, with a maximum of 5 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	2	0	2
1999	1	0	1
2000	1	0	1
2001	1	1	2
2002	2	0	2
2003	1	3	4
2004	0	1	1
2005	2	0	2
2006	4	1	5
2007	0	1	1
2008	1	2	3
2010	1	2	3
2011	1	1	2
2014	0	3	3
2020	0	1	1
2022	0	1	1
2023	0	2	2

Below are the most recent publications written about "Epitopes, T-Lymphocyte" by people in Profiles.

Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R, Tran W, Yang HT, Wang Y, Xu Y, Obusan MB, Cheng D, Lee AH, Kadash-Edmondson KE, Champhekar A, Puig-Saus C, Ribas A, Prins RM, Seet CS, Crooks GM, Witte ON, Xing Y. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proc Natl Acad Sci U S A. 2023 May 23; 120(21):e2221116120.

View in: PubMed
Qin J, Jeon JH, Xu J, Langston LK, Marasini R, Mou S, Montoya B, Melo-Silva CR, Jeon HJ, Zhu T, Sigal LJ, Xu R, Zhu H. Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine. Front Immunol. 2023; 14:1126392.

View in: PubMed
Palatnik-de-Sousa I, Wallace ZS, Cavalcante SC, Ribeiro MPF, Silva JABM, Cavalcante RC, Scheuermann RH, Palatnik-de-Sousa CB. A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron. Sci Rep. 2022 10 06; 12(1):16731.

View in: PubMed
Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020 04 08; 27(4):671-680.e2.

View in: PubMed
Veomett N, Dao T, Liu H, Xiang J, Pankov D, Dubrovsky L, Whitten JA, Park SM, Korontsvit T, Zakhaleva V, Casey E, Curcio M, Kharas MG, O'Reilly RJ, Liu C, Scheinberg DA. Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clin Cancer Res. 2014 Aug 01; 20(15):4036-46.

View in: PubMed
Ngo MC, Ando J, Leen AM, Ennamuri S, Lapteva N, Vera JF, Min-Venditti A, Mims MP, Heslop HE, Bollard CM, Gottschalk S, Rooney CM. Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203.

View in: PubMed
Snook AE. Could targeting T-helper cells aid the development of effective cancer vaccines? Immunotherapy. 2014; 6(9):959-61.

View in: PubMed
Popovic ZV, Wang S, Papatriantafyllou M, Kaya Z, Porubsky S, Meisner M, Bonrouhi M, Burgdorf S, Young MF, Schaefer L, Gr?ne HJ. The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol. 2011 Dec 15; 187(12):6217-26.

View in: PubMed
Snook AE, Magee MS, Marszalowicz GP, Schulz S, Waldman SA. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C. Cancer Immunol Immunother. 2012 May; 61(5):713-23.

View in: PubMed
Zhou F, Zhang GX, Rostami A. 3G11 expression in CD4+ T cell-mediated autoimmunity and immune tolerance. Int Immunopharmacol. 2011 May; 11(5):593-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement